From lab to ledger: a sequential policy framework for de-risking biotechnological investments in environmental sustainability
Résumé
Background While biotechnological innovations offer transformative solutions for environmental sustainability, they frequently fail to transition from laboratory “practices” to commercial “prospects” due to significant economic barriers. This “Valley of Death” is characterized by high technical uncertainty and a lack of specialized financial instruments. Objective/methods This Perspective proposes a Sequential Gate Framework designed to align policy incentives with the specific risk profiles of the biotechnological lifecycle. By categorizing development into three distinct stages R&D, Demonstration, and Market Entry, we identify the precise economic hurdles that deter private capital. Results/discussion We argue that “one-size-fits-all” funding is ineffective. Instead, a targeted sequence of interventions is required: direct subsidies for fundamental R&D, Public-Private Partnerships (PPPs) and first-loss guarantees for scaling pilot plants, and Contracts for Difference (CfD) to ensure market competitiveness against fossil-fuel incumbents. Furthermore, the integration of Digital Twins and AI is highlighted as an immediate, cutting-edge catalyst for reducing information asymmetry between biotechnologists and institutional investors. Conclusion Bridging the gap between biological potential and economic reality requires a synchronized institutional response. By adopting this sequential de-risking roadmap, policymakers can foster a resilient circular bioeconomy, ensuring that biotechnological advancements achieve the industrial scale necessary to address global environmental crises.
Citer ce document
Accès au document
Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter
Voir l'article sur le site de la revueAuteur(s)
Statistiques
Consultations : 1
Téléchargements : 0